From: Genetic association analysis of miRNA SNPs implicates MIR145 in breast cancer susceptibility
 | rs629367 | rs562052 | rs693120 | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Allele | Genotype | Allele | Genotype | Allele | Genotype | |||||||||||||||
 | A (%) | C (%) | p-value | AA (%) | CA (%) | CC (%) | p-value | G (%) | A (%) | p-value | GG (%) | AG (%) | AA (%) | p-value | G (%) | A (%) | p-value | GG (%) | AG (%) | AA (%) | p-value |
Control | 302 (82.5) | 64 (17.5) | 0.72 | 125 (68.3) | 52 (28.4) | 6 (3.3) | 0.88 | 242 (65.4) | 128 (34.6) | 0.76 | 81 (43.8) | 80 (43.2) | 24 (13.0) | 0.57 | 230 (67.3) | 112 (32.7) | 0.77 | 82 (48.0) | 66 (38.6) | 23 (13.5) | 0.21 |
Cases | 289 (83.5) | 57 (16.5) | 122 (70.5) | 45 (26.0) | 6 (3.5) | 230 (66.5) | 116 (33.5) | 74 (42.8) | 82 (47.4) | 17 (9.8) | 225 (66.2) | 115 (33.8) | 72 (42.4) | 81 (47.6) | 17 (10.0) | ||||||
Hapmap (%) | 84.6 | 15.4 | Â | 75.4 | 18.5 | 6.2 | Â | 68.1 | 31.9 | Â | 46.2 | 43.8 | 10.0 | Â | 68.1 | 31.9 | Â | 46.2 | 43.8 | 10.0 | Â |